| Reporting of stepped wedge cluster randomised trials: Extension of the CONSORT 2010 statement with explanation and elaboration K Hemming, M Taljaard, JE McKenzie, R Hooper, A Copas, JA Thompson, ... BMJ 363, k1614, 2018 | 343 | 2018 |
| Stepped wedge cluster randomized controlled trial designs: A review of reporting quality and design features MJ Grayling, JMS Wason, AP Mander Trials 18, 33, 2017 | 80 | 2017 |
| A review of perspectives on the use of randomization in phase II oncology trials MJ Grayling, M Dimairo, AP Mander, TF Jaki JNCI: Journal of the National Cancer Institute 111 (12), 1255-1262, 2019 | 43 | 2019 |
| A review of Bayesian perspectives on sample size derivation for confirmatory trials K Kunzmann, MJ Grayling, KM Lee, DS Robertson, K Rufibach, J Wason The American Statistician 75 (4), 424-432, 2021 | 34 | 2021 |
| phaseR: An R package for phase plane analysis of autonomous ODE systems MJ Grayling R Journal 6 (2), 43-51, 2014 | 31* | 2014 |
| Do single‐arm trials have a role in drug development plans incorporating randomised trials? MJ Grayling, AP Mander Pharmaceutical Statistics 15 (2), 143-151, 2015 | 30 | 2015 |
| A web application for the design of multi-arm clinical trials MJ Grayling, JMS Wason BMC Cancer 20, 80, 2020 | 24 | 2020 |
| A review of available software for adaptive clinical trial design MJ Grayling, GM Wheeler Clinical Trials 17 (3), 323-331, 2020 | 19 | 2020 |
| Group sequential designs for stepped-wedge cluster randomised trials MJ Grayling, JMS Wason, AP Mander Clinical Trials 14 (5), 507-517, 2017 | 16 | 2017 |
| Innovative trial approaches in immune-mediated inflammatory diseases: Current use and future potential MJ Grayling, T Bigirumurame, S Cherlin, L Ouma, H Zheng, J Wason BMC Rheumatology 5, 21, 2021 | 13 | 2021 |
| Blinded and unblinded sample size reestimation in crossover trials balanced for period MJ Grayling, AP Mander, JMS Wason Biometrical Journal 60 (5), 917-933, 2018 | 13 | 2018 |
| Impact of the COVID-19 lockdown on hangings attended by emergency medical services G McClelland, G Shaw, L Thompson, N Wilson, M Grayling Resuscitation 157, 89-90, 2020 | 12 | 2020 |
| Blinded and unblinded sample size reestimation procedures for stepped‐wedge cluster randomized trials MJ Grayling, AP Mander, JMS Wason Biometrical Journal 60 (5), 903-916, 2018 | 12 | 2018 |
| Quality of stepped-wedge trial reporting can be reliably assessed using an updated CONSORT: Crowd-sourcing systematic review K Hemming, K Carroll, J Thompson, A Forbes, M Taljaard, ... Journal of Clinical Epidemiology 107, 77-88, 2018 | 11 | 2018 |
| Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trials K Kunzmann, MJ Grayling, KM Lee, DS Robertson, K Rufibach, J Wason Statistics in Medicine 41 (5), 877-890, 2022 | 9 | 2022 |
| Admissible multiarm stepped‐wedge cluster randomized trial designs MJ Grayling, AP Mander, JMS Wason Statistics in Medicine 38 (7), 1103-1119, 2018 | 9 | 2018 |
| Design and analysis of umbrella trials: Where do we stand? LO Ouma, J Wason, H Zheng, N Wilson, M Grayling Frontiers in Medicine, doi:10.3389/fmed.2022.1037439, 2022 | 8 | 2022 |
| An optimised multi-arm multi-stage clinical trial design for unknown variance MJ Grayling, JMS Wason, AP Mander Contemporary Clinical Trials 67, 116-120, 2018 | 8 | 2018 |
| A stochastically curtailed single‐arm phase II trial design for binary outcomes M Law, MJ Grayling, AP Mander Journal of Biopharmaceutical Statistics 32 (5), 671-691, 2022 | 7* | 2022 |
| Two-stage single-arm trials are rarely analyzed effectively or reported adequately MJ Grayling, AP Mander JCO Precision Oncology 5, 1813-1820, 2021 | 6* | 2021 |
James WasonNewcastle UniversityVerified email at newcastle.ac.uk
